Bristol-Myers Squibb Co (NYSE:BMY)
$ 44.94 0.2 (0.45%) Market Cap: 91.10 Bil Enterprise Value: 138.84 Bil PE Ratio: 0 PB Ratio: 5.52 GF Score: 83/100

Bristol-Myers Squibb Co at Wolfe Research Healthcare Conference (Virtual) Transcript

Nov 17, 2021 / 01:45PM GMT
Release Date Price: $59.44 (+0.58%)
Timothy Minton Anderson
Wolfe Research, LLC - MD of Equity Research

Okay. Well, good morning and thank you to everyone for joining us to our Wolfe health care conference that runs today and tomorrow. We have a host of companies from my coverage, from Justin Lake's coverage, from Andrew Galler's coverage. And most of these sessions will be fireside chats. And we're going to kick things off this morning with Giovanni Caforio. He's the Chairman and CEO of Bristol-Myers Squibb. He has been with the company for quite some time, I think since 2000. And in case you missed it yesterday, the company held a very comprehensive Analyst Day, running through many aspects of the business, pipeline, key marketed products, future patent expiries, what Bristol is trying to do to stay [relevant]. And there was a lot of content. So why don't we start with some general questions, Giovanni?

Questions & Answers

Timothy Minton Anderson
Wolfe Research, LLC - MD of Equity Research

So 2021 is coming to an end, just 6 weeks left. How is the setup for 2022 looking for Bristol?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot